Zacks: Analysts Anticipate Cardiome Pharma Corp (CRME) to Announce -$0.19 EPS


Wall Street brokerages forecast that Cardiome Pharma Corp will announce earnings per share for the current fiscal quarter, according to Zacks Investment Research . Three analysts have provided estimates for Cardiome Pharma's earnings, with the highest EPS estimate coming in at and the lowest estimate coming in at .



from Biotech News